Diurnal Variation in Tear Osmolarity
Status: | Completed |
---|---|
Conditions: | Ocular |
Therapuetic Areas: | Ophthalmology |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 4/2/2016 |
Start Date: | March 2011 |
End Date: | January 2013 |
Contact: | Joan Fredrickson |
Email: | jfredrickson@ocli.net |
Phone: | 516-705-7140 |
Investigator Sponsored, Pilot Study to Assess the Diurnal Variation in Tear Osmolarity as a Predictor of Dry Eye Disease Etiology
The purpose of this study is to measure the change in Tear Osmolarity during the course of
the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and
differentiate between the two forms of dry eye.
the day to support clinical diagnosis of aqueous deficiency or meibomian gland disease and
differentiate between the two forms of dry eye.
The premise of this study is that dry eye disease, specifically tear osmolarity, changes
during the course of the day based on the etiology of the dry eye and that
aqueous-deficiency dry eye will worsen during the course of the day while meibomian gland
deficiency will stabilize or possibly even improve during the course of the day.
during the course of the day based on the etiology of the dry eye and that
aqueous-deficiency dry eye will worsen during the course of the day while meibomian gland
deficiency will stabilize or possibly even improve during the course of the day.
Inclusion Criteria:
1. Healthy males and females ≥ 18 years old
2. Negative urine pregnancy results for females of childbearing potential
3. Able to read and sign an informed consent form and show willingness to comply with
the study protocol visits and procedures
4. Has 20/40 BCVA or better in at least one eye
5. Does not currently wear contact lenses
6. For Aqueous-Deficiency Group:
- Has symptoms of Dry Eye
- Schirmer testing ≤ 10 mm
- Tear Break Up Time ≤ 8 seconds
- Conjunctival staining ≥ 1+
- Meibomian gland inspissations ≤ 1+
- No lid thickening, lid erythema, or thickened, turbid meibomian gland secretions
7. For Meibomian Gland Disease Group:
- Has symptoms of Dry Eye
- Schirmer testing ≥ 10 mm
- Tear Break Up Time ≤ 8 seconds
- Conjunctival staining ≥ 1+
- Meibomian gland inspissations ≥ 2+
8. For Normal Group:
- Has no symptoms of Dry Eye
- Schirmer testing > 10 mm
- Tear Break Up Time > 8 seconds
- No or trace Conjunctival staining
- No Meibomian gland inspissations
Exclusion Criteria:
1. Any topical medication within the last three months, except for artificial tears
2. Unable to discontinue use of artificial tears during the course of the day for Visit
2
3. Any Systemic disease, which in the opinion of the Investigator, may affect ocular
health or confound study results
4. Any active ocular disease other than Dry Eye Disease, Meibomian Gland Disease or
Sjogren's Syndrome, which in the opinion of the Investigator, may affect ocular
health or confound study results
5. Clinically significant lid or conjunctival abnormalities, neovascularization, corneal
scars or corneal opacities
6. Clinically significant limbal or bulbar injection, or corneal staining not due to DES
7. Has worn hard or rigid gas permeable contact lenses within 1 year
8. Has worn soft contact lenses within 1 week
9. Has had eye surgery or an eye injury within 6 months
10. Positive urine pregnancy results for females of childbearing potential
11. Any changes in current medication within 30 days of Visit 2 or anticipated change
during course of study, which in the opinion of the Investigator may confound study
results
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials